Zhenquan Hu

2.1k total citations · 1 hit paper
33 papers, 1.3k citations indexed

About

Zhenquan Hu is a scholar working on Molecular Biology, Hematology and Pharmacology. According to data from OpenAlex, Zhenquan Hu has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Hematology and 8 papers in Pharmacology. Recurrent topics in Zhenquan Hu's work include Microbial Natural Products and Biosynthesis (8 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Fungal Biology and Applications (7 papers). Zhenquan Hu is often cited by papers focused on Microbial Natural Products and Biosynthesis (8 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Fungal Biology and Applications (7 papers). Zhenquan Hu collaborates with scholars based in China, United States and Switzerland. Zhenquan Hu's co-authors include Shuguang Yuan, H. C. Stephen Chan, Qingsong Liu, Angelo Vedani, Shugeng Cao, Martin Smieško, Max Dobler, Jing Liu, Horst Vogel and Sławomir Filipek and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Zhenquan Hu

33 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Using PyMOL as a platform for computational drug design

2017 617 citations Shuguang Yuan, H. C. Stephen Chan et al. Wiley Interdisciplinary Reviews Computational Molecular Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhenquan Hu China	16	648	256	224	161	114	33	1.3k
Sarah Naomi Bolz Germany	8	757 1.2×	249 1.0×	300 1.3×	146 0.9×	44 0.4×	12	1.4k
Tuomo Laitinen Finland	26	970 1.5×	354 1.4×	193 0.9×	278 1.7×	130 1.1×	90	1.8k
Martiniano Bello Mexico	22	816 1.3×	220 0.9×	281 1.3×	101 0.6×	59 0.5×	99	1.4k
Katrin Stierand Germany	10	677 1.0×	230 0.9×	304 1.4×	134 0.8×	40 0.4×	15	1.2k
Mohd Shahbaaz South Africa	19	632 1.0×	133 0.5×	203 0.9×	97 0.6×	46 0.4×	56	1.2k
Mario S. Valdés‐Tresanco Colombia	8	1.1k 1.6×	338 1.3×	464 2.1×	156 1.0×	71 0.6×	11	2.0k
Prabha Garg India	24	681 1.1×	251 1.0×	448 2.0×	180 1.1×	42 0.4×	111	1.6k
Makoto Muroi Japan	25	1.2k 1.8×	382 1.5×	124 0.6×	290 1.8×	160 1.4×	78	1.8k
Isaac M. Westwood United Kingdom	26	1.1k 1.6×	207 0.8×	160 0.7×	93 0.6×	67 0.6×	45	1.6k
Mario E. Valdés‐Tresanco Cuba	11	1.1k 1.7×	364 1.4×	467 2.1×	167 1.0×	73 0.6×	24	2.1k

Countries citing papers authored by Zhenquan Hu

Since Specialization

Citations

This map shows the geographic impact of Zhenquan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenquan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenquan Hu more than expected).

Fields of papers citing papers by Zhenquan Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenquan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenquan Hu. The network helps show where Zhenquan Hu may publish in the future.

Co-authorship network of co-authors of Zhenquan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenquan Hu. A scholar is included among the top collaborators of Zhenquan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenquan Hu. Zhenquan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Qader, Mallique, et al.. (2021). Aspochalasin H1: A New Cyclic Aspochalasin from Hawaiian Plant-Associated Endophytic Fungus Aspergillus sp. FT1307. Molecules. 26(14). 4239–4239. 7 indexed citations

2.

Park, Jae Hyeon, et al.. (2021). Secondary Metabolites from the Leather Coral-Derived Fungal Strain Xylaria sp. FM1005 and Their Glycoprotein IIb/IIIa Inhibitory Activity. Journal of Natural Products. 84(2). 466–473. 13 indexed citations

3.

Lu, Tingting, Fengming Zou, Xixiang Li, et al.. (2021). Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML). European Journal of Pharmacology. 897. 173944–173944. 8 indexed citations

4.

Wang, Beilei, Xuesong Liu, Fengming Zou, et al.. (2020). Discovery of (E)-N-(4-methyl-5-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thiazol-2-yl)-2-(4-methylpiperazin-1-yl)acetamide (IHMT-TRK-284) as a novel orally available type II TRK kinase inhibitor capable of overcoming multiple resistant mutants. European Journal of Medicinal Chemistry. 207. 112744–112744. 15 indexed citations

5.

Wu, Xiaohua, Zhenquan Hu, Wesley Y. Yoshida, et al.. (2020). Antibacterial kaneoheoic acids A-F from a Hawaiian fungus Fusarium sp. FM701. Phytochemistry. 181. 112545–112545. 9 indexed citations

6.

Hu, Zhenquan, et al.. (2020). Tryptoquivalines W and X, two new compounds from a Hawaiian fungal strain and their biological activities. Tetrahedron Letters. 61(14). 151730–151730. 12 indexed citations

7.

Li, Feng, Xiaofei Liang, Zongru Jiang, et al.. (2020). Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease. Journal of Medicinal Chemistry. 63(22). 13973–13993. 12 indexed citations

8.

Wang, Wenliang, Zongru Jiang, Chen Hu, et al.. (2020). Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52. Acta Pharmacologica Sinica. 42(4). 633–640. 30 indexed citations

9.

Liu, Xuesong, Beilei Wang, Cheng Chen, et al.. (2019). Discovery of (E)-N¹-(3-Fluorophenyl)-N³-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)malonamide (CHMFL-KIT-033) as a Novel c-KIT T670I Mutant Selective Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs). Journal of Medicinal Chemistry. 62(10). 5006–5024. 16 indexed citations

10.

Liang, Xiaofei, Zongru Jiang, Zhenghui Huang, et al.. (2019). Discovery of 6′-chloro-N-methyl-5’-(phenylsulfonamido)-[3,3′-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium. European Journal of Medicinal Chemistry. 188. 112012–112012. 16 indexed citations

11.

Wu, Yun, Beilei Wang, Junjie Wang, et al.. (2019). Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of c-KIT Kinase for Gastrointestinal Stromal Tumors. Journal of Medicinal Chemistry. 62(13). 6083–6101. 13 indexed citations

12.

Lu, Tingting, Cheng Chen, Aoli Wang, et al.. (2019). Repurposing cabozantinib to GISTs: Overcoming multiple imatinib-resistant cKIT mutations including gatekeeper and activation loop mutants in GISTs preclinical models. Cancer Letters. 447. 105–114. 12 indexed citations

13.

Liang, Xiaofei, Cheng Chen, Zongru Jiang, et al.. (2018). Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor. European Journal of Medicinal Chemistry. 156. 831–846. 12 indexed citations

14.

Zhang, Zhimin, Ka‐Wai Ma, Linfeng Gao, et al.. (2017). Mechanism of host substrate acetylation by a YopJ family effector. Nature Plants. 3(8). 17115–17115. 52 indexed citations

15.

Yuan, Shuguang, H. C. Stephen Chan, & Zhenquan Hu. (2017). Using PyMOL as a platform for computational drug design. Wiley Interdisciplinary Reviews Computational Molecular Science. 7(2). 617 indexed citations breakdown →

16.

Yuan, Shuguang, H. C. Stephen Chan, & Zhenquan Hu. (2017). Implementing WebGL and HTML5 in Macromolecular Visualization and Modern Computer-Aided Drug Design. Trends in biotechnology. 35(6). 559–571. 27 indexed citations

17.

Liang, Xiaofei, Beilei Wang, Fengming Zou, et al.. (2016). Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid Leukemia. Journal of Medicinal Chemistry. 59(5). 1984–2004. 14 indexed citations

18.

Wang, Qiang, Feiyang Liu, Beilei Wang, et al.. (2016). Discovery of N-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs). Journal of Medicinal Chemistry. 59(8). 3964–3979. 8 indexed citations

19.

Yuan, Shuguang, Zhenquan Hu, Sławomir Filipek, & Horst Vogel. (2014). W246^6.48 Opens a Gate for a Continuous Intrinsic Water Pathway during Activation of the Adenosine A_2A Receptor. Angewandte Chemie International Edition. 54(2). 556–559. 67 indexed citations

20.

Yuan, Shuguang, Zhenquan Hu, Sławomir Filipek, & Horst Vogel. (2014). W246^6.48 Opens a Gate for a Continuous Intrinsic Water Pathway during Activation of the Adenosine A_2A Receptor. Angewandte Chemie. 127(2). 566–569. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact